| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 71, 152-156, Copyright © 1990 by Endocrine Society
ARTICLES |
A Rabinovitch, W Sumoski, RV Rajotte and GL Warnock
Department of Medicine, University of Alberta, Edmonton, Canada.
Interleukin-1 (IL-1), tumor necrosis factor (TNF), and interferon-gamma (IFN gamma) inhibit insulin release and may be cytotoxic to isolated rodent pancreatic islets. In this study we examined the effects of IL- 1, TNF, and IFN gamma on the viability and hormone secretion of islets isolated from adult human pancreas and maintained in monolayer culture. IL-1 and TNF were cytotoxic to the islet cells (20-30% cell lysis) in a 51Cr release cytotoxicity assay, and IFN gamma had only small effects (less than 10% lysis). Combination of maximally cytotoxic concentrations of IL-1 (10 U/mL) and TNF (10(3) U/mL) produced an additive cytotoxic effect. IFN gamma (10(3) U/mL) acted synergistically with IL-1 and TNF, and the three cytokines added together produced maximal islet cell lysis (46.4 +/- 4.3%). Assay of insulin and glucagon in the islet monolayers revealed that IL-1, TNF, and IFN gamma inhibited both B- and A-cell secretory functions; however, only IL-1 and TNF produced permanent decreases in insulin and glucagon contents in the islet cultures. These findings indicate that IL-1 and TNF, as single agents, are cytotoxic to human islet cells, and that this cytotoxicity can be amplified by combining the cytokines and/or adding IFN gamma. However, the lack of specificity for B-cells in vitro suggests that additional factors might be operative in vivo for the cytokine products of macrophages and lymphocytes infiltrating islets to produce the B-cell-specific damage characteristic of type 1 diabetes.
This article has been cited by other articles:
![]() |
K. ALEXANDRAKI, C. PIPERI, C. KALOFOUTIS, J. SINGH, A. ALAVERAS, and A. KALOFOUTIS Inflammatory Process in Type 2 Diabetes: The Role of Cytokines Ann. N.Y. Acad. Sci., November 1, 2006; 1084(1): 89 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Maedler, D. M. Schumann, N. Sauter, H. Ellingsgaard, D. Bosco, R. Baertschiger, Y. Iwakura, J. Oberholzer, C. B. Wollheim, B. R. Gauthier, et al. Low Concentration of Interleukin-1{beta} Induces FLICE-Inhibitory Protein-Mediated {beta}-Cell Proliferation in Human Pancreatic Islets. Diabetes, October 1, 2006; 55(10): 2713 - 2722. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Narang and R. I. Mahato Biological and biomaterial approaches for improved islet transplantation. Pharmacol. Rev., June 1, 2006; 58(2): 194 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Hering, R. Kandaswamy, J. D. Ansite, P. M. Eckman, M. Nakano, T. Sawada, I. Matsumoto, S.-H. Ihm, H.-J. Zhang, J. Parkey, et al. Single-Donor, Marginal-Dose Islet Transplantation in Patients With Type 1 Diabetes JAMA, February 16, 2005; 293(7): 830 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sen, S. Bhattacharyya, M. Wallet, C. P. Wong, B. Poligone, M. Sen, A. S. Baldwin Jr., and R. Tisch NF-{kappa}B Hyperactivation Has Differential Effects on the APC Function of Nonobese Diabetic Mouse Macrophages J. Immunol., February 15, 2003; 170(4): 1770 - 1780. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Van de Casteele, B. A. Kefas, Z. Ling, H. Heimberg, and D. G. Pipeleers Specific Expression of Bax-{omega} in Pancreatic {beta}-Cells Is Down-Regulated by Cytokines before the Onset of Apoptosis Endocrinology, January 1, 2002; 143(1): 320 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. GILL Use of Small Animal Models for Screening Immunoisolation Approaches to Cellular Transplantation Ann. N.Y. Acad. Sci., November 1, 2001; 944(1): 35 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W.R. GRAY An Overview of the Immune System with Specific Reference to Membrane Encapsulation and Islet Transplantation Ann. N.Y. Acad. Sci., November 1, 2001; 944(1): 226 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hoorens, G. Stangé, D. Pavlovic, and D. Pipeleers Distinction Between Interleukin-1-Induced Necrosis and Apoptosis of Islet Cells Diabetes, March 1, 2001; 50(3): 551 - 557. [Abstract] [Full Text] |
||||
![]() |
C. J. WEBER, S. SAFLEY, M. HAGLER, and J. KAPP Evaluation of Graft-Host Response for Various Tissue Sources and Animal Models Ann. N.Y. Acad. Sci., June 18, 1999; 875(1): 233 - 254. [Abstract] [Full Text] |
||||
![]() |
C. M. Larsen, K. A. W. Wadt, L. F. Juhl, H. U. Andersen, A. E. Karlsen, M. S.-S. Su, K. Seedorf, L. Shapiro, C. A. Dinarello, and T. Mandrup-Poulsen Interleukin-1beta -induced Rat Pancreatic Islet Nitric Oxide Synthesis Requires Both the p38 and Extracellular Signal-regulated Kinase 1/2 Mitogen-activated Protein Kinases J. Biol. Chem., June 12, 1998; 273(24): 15294 - 15300. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dahlen, K. Dawe, L. Ohlsson, and G. Hedlund Dendritic Cells and Macrophages Are the First and Major Producers of TNF-{alpha} in Pancreatic Islets in the Nonobese Diabetic Mouse J. Immunol., April 1, 1998; 160(7): 3585 - 3593. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Delaney, D. Pavlovic, A. Hoorens, D. G. Pipeleers, and D. L. Eizirik Cytokines Induce Deoxyribonucleic Acid Strand Breaks and Apoptosis in Human Pancreatic Islet Cells Endocrinology, June 1, 1997; 138(6): 2610 - 2614. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |